IMPAX LABORATORIES INC's ticker is IPXL and the CUSIP is 45256B101. A total of 2 filers reported holding IMPAX LABORATORIES INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $866,634,000 | +54.6% | 44,557 | +32.4% | 0.00% | – |
| Q4 2017 | $560,539,000 | -18.0% | 33,666 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $683,419,000 | +28.0% | 33,666 | +1.5% | 0.00% | 0.0% |
| Q2 2017 | $533,860,000 | +9.6% | 33,159 | -13.9% | 0.00% | – |
| Q1 2017 | $487,127,000 | +238687.7% | 38,508 | +149.8% | 0.00% | – |
| Q4 2016 | $204,000 | -99.2% | 15,416 | -98.5% | 0.00% | -100.0% |
| Q3 2016 | $24,426,000 | -40.3% | 1,030,579 | -27.5% | 0.03% | -43.5% |
| Q2 2016 | $40,943,000 | -14.0% | 1,420,630 | -4.5% | 0.05% | -16.4% |
| Q1 2016 | $47,611,000 | -39.1% | 1,486,880 | -18.7% | 0.06% | -38.2% |
| Q4 2015 | $78,174,000 | +25.4% | 1,828,215 | +3.2% | 0.09% | +29.0% |
| Q3 2015 | $62,357,000 | -23.0% | 1,771,009 | +0.5% | 0.07% | -10.4% |
| Q2 2015 | $80,932,000 | -14.6% | 1,762,461 | -12.8% | 0.08% | -15.4% |
| Q1 2015 | $94,767,000 | +42.3% | 2,021,931 | -3.8% | 0.09% | +44.4% |
| Q4 2014 | $66,607,000 | +25.8% | 2,102,479 | -5.8% | 0.06% | +21.2% |
| Q3 2014 | $52,931,000 | -19.5% | 2,232,414 | +1.8% | 0.05% | -21.2% |
| Q2 2014 | $65,753,000 | +8.4% | 2,192,509 | -4.5% | 0.07% | +1.5% |
| Q1 2014 | $60,676,000 | +5.5% | 2,296,618 | +0.4% | 0.06% | -1.5% |
| Q4 2013 | $57,515,000 | +33.1% | 2,287,838 | +8.6% | 0.07% | +24.5% |
| Q3 2013 | $43,221,000 | +0.3% | 2,107,324 | -2.4% | 0.05% | -5.4% |
| Q2 2013 | $43,073,000 | – | 2,159,059 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aravt Global | 3,071,878 | $131,354,000 | 13.28% |
| BANBURY PARTNERS LLC | 480,179 | $20,532,000 | 8.33% |
| Krensavage Asset Management, LLC | 585,170 | $25,022,000 | 7.98% |
| Hound Partners | 6,980,266 | $298,476,000 | 6.77% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 295,000 | $12,614,000 | 4.25% |
| GIOVINE CAPITAL GROUP LLC | 59,805 | $2,557,000 | 3.72% |
| ATERNALIS CAPITAL LLC | 130,000 | $5,559,000 | 3.65% |
| Asymmetry Capital Management, L.P. | 51,430 | $2,199,000 | 3.32% |
| Orbimed Advisors | 6,664,100 | $284,957,000 | 2.58% |
| Pennant Capital Management, LLC | 2,321,581 | $99,271,000 | 2.52% |